Skip to main content
Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
26.79
+0.15 (0.56%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Genmab Revenue

In the year 2025, Genmab had annual revenue of $3.72B with 19.19% growth. Genmab had revenue of $1.06B in the quarter ending December 31, 2025, with 3.03% growth.

Revenue (ttm)
$3.72B
Revenue Growth
+19.19%
P/S Ratio
4.37
Revenue / Employee
$1,251,261
Employees
2,973
Market Cap
16.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.72B599.00M19.19%
Dec 31, 20243.12B731.00M30.59%
Jan 1, 20242.39B305.95M14.68%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Incyte 5.36B
Jazz Pharmaceuticals 4.27B
BioMarin Pharmaceutical 3.22B
Exelixis 2.32B
Moderna 1.94B
Madrigal Pharmaceuticals 958.40M
Ionis Pharmaceuticals 943.71M
Ascendis Pharma 845.52M
Revenue Rankings

GMAB News

More News